Krishna Institu.Q1 FY27
Krishna Institu. Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹771P/E: 157.6Market Cap: ₹32.9K CrSector: Healthcare Services
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- →KIMS Hospitals expects year-on-year growth in top line and bottom line, aiming to maintain historical growth rates seen over the last 10-15 years. (Page 23)
- →Core markets like Telangana, Andhra Pradesh, Maharashtra, Karnataka, and Kerala will be the focus for growth, mainly via greenfield projects and acquisitions. (Pages 19, 23)
- →New hospitals like Kondapur and Rajahmundry are expected to scale up, with Kondapur showing a 40% revenue growth shortly after commissioning. (Pages 17, 18)
- →Andhra Pradesh cluster shows strong, continuous growth with addition of specialties like cancer care aiding ARPOB increase. (Page 17)
- →Utilization in mature clusters is at around 61%-65%, expected to improve to 65%-70% by FY 2030 without adding bed capacity. (Page 15)
- →They project healthy 20% year-on-year revenue growth in Bangalore and Maharashtra clusters post-stabilization. (Page 12)
- →Conservative ARPOB growth guidance at 4%-5% going forward. (Page 15)
Margin guidance
Category 3- →KIMS Hospitals expects year-on-year growth in both topline and bottomline, aiming to maintain the historical growth trajectory of the past 10-15 years. (Page 23)
- →EBITDA margins in mature clusters like Telangana are expected to stabilize around 30%-35% once new expansions mature. (Page 19, 22)
- →Kerala cluster margins are expected around 22%-23%, acknowledging some entry costs but no structural margin impediments. (Page 19)
- →Operating cash flow is projected to exceed INR 2,500 crore over next 3-4 years, with internal accruals primarily reinvested into growth rather than debt reduction. (Page 19)
- →Focus on stabilizing existing hospitals before new greenfield expansions in FY '28 and beyond, anticipating profitable growth. (Page 8, 23)
- →EPS for FY '26 was INR 104; near-term profits may see fluctuations due to new hospital ramp-up and CAPEX cycle, but long-term outlook remains positive. (Pages 3, 22)
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →Recently completed a Qualified Institutional Placement (QIP) raising INR 1,500 crores, which was oversubscribed.
- →INR 1,100 crores of QIP proceeds have already been used to reduce debt.
- →Preferential allotment to promoters of INR 600 crores approved; 25% to be infused initially, balance later.
- →Management is maintaining a cautious approach to debt, targeting a debt-equity ratio of around 2.5:1.
- →No explicit mention of immediate future fundraising through debt or equity; focus is on consolidating and growing within existing financial structure.
- →Internal accruals expected to be primarily used for expansion and CAPEX rather than further debt reduction in the near term.
Order book
The document does not explicitly mention any current or expected orderbook or pending orders for KIMS Hospitals. However, relevant insights related to growth opportunities and expansions include:
- Focus on core markets for acquisitions: Maharashtra, Kerala, Telangana, Andhra Pradesh.
- Karnataka growth primarily via greenfield projects.
- Typical acquisition targets: hospitals with 300-350 beds, scalable by ~100 beds.
- Pursuit of acquisitions and greenfield projects is ongoing but uncertain; no definite numbers on closures.
- Several O&M (Operations & Maintenance) agreements with hospitals in Telangana and Andhra pending integration and potential acquisition.
- Emphasis on stabilizing recently commissioned hospitals before further expansions.
- Plans to balance debt and growth cautiously; expected continued year-on-year top line and bottom line growth.
No specific orderbook or pending orders are cited.
Capex plans
Yes- →Current FY '27 CAPEX is around INR 100-125 crore over the next nine months, mostly tied to Rajahmundry hospital (INR 60-75 crore) and minor additional spend in Kondapur and Secunderabad.
- →Maintenance CAPEX is estimated at around INR 100 crore per year for the next 3-4 years.
- →Majority of new CAPEX has been completed; future spends will be more focused on consolidating existing assets.
- →New greenfield hospital opportunities (~300-350 beds, scalable by 100 beds) are primarily planned for FY '28 onwards in core markets (Maharashtra, Kerala, Telangana, Andhra Pradesh); Karnataka will continue via greenfield route.
- →Brownfield expansions in Kerala, Telangana, Maharashtra are shortlisted and will be pursued when timing is right.
- →Internal accruals and QIP proceeds are being used for debt reduction and growth-related investments while maintaining prudent debt-equity ratios (~2.5:1).
How does Krishna Institu. rank vs peers in Healthcare Services?
Pro feature1Krishna Institu.
Rev 3Mar 3
See full Healthcare Services sector rankings
How does Krishna Institu. rank in Healthcare Services?
Compare Krishna Institu. against every Healthcare Services company (Q1 FY27) on revenue, margins and earnings-call signals.